Game Plan Financial Advisors, LLC Caladrius Biosciences, Inc. Transaction History

Game Plan Financial Advisors, LLC

  • $180 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.83 - $1.22 $14,110 - $20,740
-17,000 Closed
0 $0
Q3 2021

Oct 26, 2021
SELL
$1.15 - $1.57 $9,200 - $12,560
-8,000 Reduced 32.0%
17,000 $21,000
Q2 2021

Jul 14, 2021
BUY
$1.4 - $1.9 $14,000 - $19,000
10,000 Added 66.67%
25,000 $40,000
Q1 2021

Apr 28, 2021
BUY
$1.44 - $2.89 $21,600 - $43,350
15,000 New
15,000 $29,000

About CALADRIUS BIOSCIENCES, INC.

CLBS Quotes by TradingView
  • Ticker CLBS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,583,200
  • Market Cap $25.8M
  • Description
  • Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...
More about CLBS
Track This Portfolio

Track Game Plan Financial Advisors, LLC Portfolio

Follow Game Plan Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email